NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Anemia Workup
    Anemia Workup
    medium
    stethoscope Medicine

    A 38-year-old woman from rural Maharashtra presents with a 6-month history of progressive fatigue, dyspnea on exertion, and palpitations. On examination, she is pale with a heart rate of 102/min. Laboratory findings: Hb 7.2 g/dL, MCV 62 fL, MCH 18 pg, serum iron 28 µg/dL (normal 60–170), ferritin 8 ng/mL (normal 12–200), TIBC 420 µg/dL (normal 250–425). Peripheral blood smear shows microcytic hypochromic RBCs with target cells. What is the most appropriate next step in management?

    A. Administer intravenous iron sucrose 200 mg weekly for 5 weeks
    B. Perform upper and lower gastrointestinal endoscopy to identify source of blood loss
    C. Initiate oral ferrous sulfate 200 mg daily and recheck hemoglobin in 3 weeks
    D. Obtain serum transferrin saturation and soluble transferrin receptor levels

    Explanation

    ## Clinical Context This patient presents with **iron deficiency anemia (IDA)** with clear biochemical confirmation: low serum iron, low ferritin, elevated TIBC, and microcytic hypochromic indices. The diagnosis is established. ## Rationale for Correct Answer **Key Point:** Once iron deficiency anemia is biochemically confirmed, the immediate next step is to **initiate iron replacement therapy**, not to investigate the cause first. In India, the most common causes of IDA are: - Nutritional deficiency (especially in rural/lower socioeconomic populations) - Chronic blood loss (GI, menstrual, hookworm) Oral iron therapy is the **first-line and preferred route** in uncomplicated IDA: - Ferrous salts (sulfate, gluconate, fumarate) are most bioavailable - Standard dose: 200 mg elemental iron daily - Expected reticulocytosis in 3–5 days - Hemoglobin rise of 1–2 g/dL per month - Cost-effective and well-tolerated in most patients **Clinical Pearl:** Response to iron therapy is itself diagnostic — a rising reticulocyte count and hemoglobin within 3 weeks confirms iron deficiency and rules out other causes of microcytic anemia (thalassemia trait, sideroblastic anemia). ## When to Investigate the Cause Investigation for the **source of blood loss** (endoscopy, imaging) is warranted **after**: 1. Confirming response to iron therapy (therapeutic trial) 2. In post-menopausal women or men (no physiologic blood loss) 3. If anemia is severe (Hb < 5 g/dL) or symptomatic 4. If there is clinical suspicion of GI malignancy This patient is pre-menopausal; menstrual loss or nutritional deficiency is most likely. Endoscopy is not the immediate next step. ## Why Not IV Iron or Further Testing? - **IV iron** is reserved for: malabsorption, intolerance to oral iron, or need for rapid repletion (pregnancy, pre-operative) - **Transferrin saturation & sTfR** are confirmatory tests, not management steps; they add no value once diagnosis is made [cite:Harrison 21e Ch 97] ![Anemia Workup diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/13465.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions